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Abstract
Alterations in the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor (AMPA-R) and N-methyl-D-aspartate receptor
(NMDA-R) have been documented in aged animals and may contribute to changes in hippocampal-dependent memory. Growth hormone
(GH) regulates AMPA-R and NMDA-R-dependent excitatory transmission and decreases with age. Chronic GH treatment mitigates
age-related cognitive decline. An in vitro CA1 hippocampal slice preparation was used to compare hippocampal excitatory transmission and
plasticity in old animals treated for 6–8 months with either saline or GH. Our findings indicate that GH treatment restores NMDA-R-
dependent basal synaptic transmission in old rats to young adult levels and enhances both AMPA-R-dependent basal synaptic transmission
and long-term potentiation. These alterations in synaptic function occurred in the absence of changes in presynaptic function, as measured
by paired-pulse ratios, the total protein levels of AMPA-R and NMDA-R subunits or in plasma or hippocampal levels of insulin-like growth
factor-I. These data suggest a direct role for GH in altering age-related changes in excitatory transmission and provide a possible cellular
mechanism through which GH changes the course of cognitive decline.
© 2012 Elsevier Inc. All rights reserved.
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Growth hormone (GH) plays an important role in the
central nervous system throughout the lifespan. GH is se-
creted by the anterior pituitary and is involved in neural
processes including neurogenesis, gliogenesis, cell migra-
tion, and differentiation, synaptogenesis, and myelination,
as well as neuroprotection (Aberg, 2010; Aberg et al., 2006,
Aberg et al., 2010; Isgaard et al., 2007). GH levels are high
during development and puberty, and then decline with
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10.1016/j.neurobiolaging.2011.09.014advancing age (Sonntag et al., 1980). Correlated with this
decline is a reduction in cognitive function in rodents, dem-
onstrated by an age-related impairment in performance on
the Morris water maze (MWM), a hippocampal-dependent
test of spatial learning and memory (Fischer et al., 1989;
Frick et al., 1995; Olton and Werz, 1978; Rapp et al., 1987;
Rosenzweig et al., 1997). Interestingly, old rats receiving 4
to 8 months of GH treatment perform significantly better on
the MWM than age-matched, untreated controls (Ramsey et
al., 2004), suggesting that GH can mitigate the age-related
changes in hippocampal function that underlie this cognitive
impairment.
The GH-induced mitigation of impaired hippocampal
function may occur as a result of modulating glutamatergic
synaptic transmission in the hippocampus. Glutamate is the
nr
C
w
u
q
N
1939D.P. Molina et al / Neurobiology of Aging 33 (2012) 1938–1949primary excitatory neurotransmitter in the hippocampus and
glutamatergic synaptic transmission involves the activation
of ionotropic receptors which include the -amino-3-
hydroxy-5-methyl-4-isoxazole propionate (AMPA)-and N-
methyl-D-aspartate (NMDA)-types of glutamate receptors
(Hollmann and Heinemann, 1994). The hippocampal levels
of these receptors are related to performance on the MWM
task (Adams et al., 2001; Tsien et al., 1996) and they
mediate long-term potentiation (LTP), a process thought to
underlie learning and memory (Bliss and Lomo, 1973; Mor-
ris et al., 1986). Importantly, changes in the subunits that
comprise AMPA and NMDA receptors (AMPA-R and
NMDA-R) have a significant impact on basal synaptic
transmission as well as LTP (Cao et al., 2007; Granger et
al., 1996; Lynch et al., 2006; Tang et al., 1999; Tsien et al.,
1996) and there are age-related changes in basal synaptic
transmission (Barnes et al., 1997; Eckles-Smith et al.,
2000), LTP (Clayton et al., 2002; Eckles-Smith et al., 2000;
Woodruff-Pak et al., 2010) and the protein levels of indi-
vidual subunits have been reported to decline with age
(Adams et al., 2008; Magnusson, 1998; Newton et al., 2008;
Shi et al., 2006, 2007; Sonntag et al., 2000). Finally, in old
rats, GH has been found to regulate the levels of the
NMDA-R subunit transcript levels (Le Grevès et al., 2002).
Thus, GH may ameliorate hippocampal-dependent cogni-
tive decline by regulating AMPA-Rs and NMDA-Rs.
It is known that insulin-like growth factor-I (IGF-I) can
serve as an anabolic mediator of the biological effects of
GH. IGF-I has been shown to alter short-term presynaptic
facilitation (Ramsey et al., 2004), AMPA-R-mediated syn-
aptic transmission (Ramsey et al., 2005; Wang and Linden,
2000), and LTP (Trejo et al., 2007). Nevertheless, GH itself
has been shown to directly modulate glutamatergic synaptic
transmission in the CA1 region of hippocampus. Specifi-
cally, acute GH application enhanced compound and phar-
macologically isolated NMDA-R and AMPA-R field excit-
atory postsynaptic potentials (fEPSPs) in hippocampal
slices not only from young rats (Mahmoud and Grover,
2006), but also from old rats (Molina et al., unpublished
observations) at an age when the GH-induced amelioration
of cognitive impairment has been shown to occur (Ramsey
et al., 2004). These reports, together with the presence of
GH receptor mRNA in the brain (Burton et al., 1992; Fraser
et al., 1990; Hull and Harvey, 1998; Lobie et al., 1993,
2000; Walsh et al., 1990; Zhai et al., 1994) and evidence
that GH crosses the blood brain barrier (Pan et al., 2005),
suggest that GH may directly influence glutamate receptor
function. The direct positive modulatory effect of GH on
excitatory synaptic transmission in the hippocampus pro-
vides a potential mechanism for the GH-induced ameliora-
tion of cognitive function in aged rats.
Although acute application of GH can directly enhance
synaptic transmission in hippocampal slices from old rats,
no studies to date have determined if the regimen of chronic
GH treatment that has been shown to mitigate age-related lcognitive impairment in old rats also results in the enhance-
ment of glutamatergic synaptic function in old rats. To
address this issue, we have compared basal excitatory syn-
aptic transmission and LTP in the hippocampal CA1 region
of old rats treated with GH for 6–8 months with that in
young adult and old saline-treated rats. Our results indicate
that 6–8 months of GH treatment restores NMDA-R-de-
pendent basal glutamatergic synaptic transmission in CA1
region in old rats to young adult levels and enhances both
AMPA-R-dependent basal glutamatergic synaptic transmis-
sion and LTP in the CA1 region in old rats above the levels
in young adult rats, but does not alter presynaptic release, as
measured by paired-pulse ratios. These effects of chronic
GH treatment occur in the absence of significant changes in
overall tissue levels of NMDA and AMPA glutamate re-
ceptor subunits, or increases in plasma or hippocampal
levels of IGF-I.
2. Methods
2.1. Animals
Young (9–11 months; n  33) and old (29–31 months;
 76) male Fisher 344  Brown Norway (F344 X BN)
ats were obtained from the National Institute of Aging
olony at Harlan Sprague Dawley. One half of the old rats
ere subcutaneously injected with 300 g of porcine GH
twice daily for 6–8 months (O-GH). All animals were
treated at the same time and 36 animals were used for the
protein and IGF-I analyses and the remaining 73 were used
for the electrophysiological studies. The dosage and regi-
men employed have been demonstrated to result in im-
proved MWM function in old rats (Ramsey et al., 2004).
The other half of the old rats and all of the young rats were
injected with saline (O-S and Y-S, respectively) for the
same time period. Body weights were recorded every 2
weeks for the duration of the study. The animal protocol for
this study conforms to National Institute of Health guide-
lines for the care and use of laboratory animals and was
approved by the Animal Care and Use Committee of Wake
Forest University Health Sciences.
2.2. Drug preparation
Porcine GH (Ozbiopharm, Knoxfield, Australia) was pre-
pared as a stock solution in deionized water. For the pharma-
cological isolation of AMPA-R-dependent fEPSPs the drug,
DL-2-amino-5-phosphonovaleric acid (APV; Sigma, St. Louis,
MO, USA; 20 M), a selective NMDA receptor blocker was
sed. To isolate the NMDA-R-dependent fEPSPs, 6,7-dinitro-
uinoxaline-2,3-dione (DNQX, Sigma, St. Louis, MO, 50
M), a selective AMPA/kainic acid (KA) receptor blocker,
combined with bicuculline methylbromide (BIC; Sigma; 20
M) a -aminobutyric acid type A (GABAA) channel blocker,
and glycine (Sigma; 1 M), an allosteric modulator of
MDA-Rs were used. The drugs were prepared as stock so-
utions in dimethyl sulfoxide (DMSO; Sigma; final concentra-
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bicuculline methylbromide.
2.3. Hippocampal slice preparation
Rats to be used for hippocampal slice recordings were
anesthetized with halothane (Sigma) and decapitated with a
guillotine. The brains were removed and submerged in
chilled, oxygenated artificial cerebrospinal fluid (aCSF)
containing 124 mM NaCl, 3.3 mM KCl, 2.4 mM MgCl2, 2.5
M Ca Cl2, 1.2 mM KH2PO4, 10-D-glucose, and 25.9 mM
NaHCO3 and saturated with 95% O2-5% CO2. Right and
left hemispheres were separated and cut coronally into
400-m thick slices using a vibratome (Leica VT1000S;
Vashaw Scientific, Atlanta, GA, USA). The hippocampus in
each slice was dissected from surrounding tissue, and equil-
ibrated in an incubation chamber with oxygenated aCSF at
20–25 °C for 90 minutes. During experiments, slices were
placed in a recording chamber and perfused with oxygen-
ated aCSF at a flow rate of 2 mL/minute at 32 °C.
2.4. Electrophysiology
Basal synaptic transmission, paired-pulse ratios and LTP
were studied by eliciting fEPSPs in hippocampal slices.
Recording electrodes were prepared from filamented boro-
silicate glass capillary tubes (0.86 mm inner diameter) using
a horizontal micropipette puller (Sutter P-97; Sutter, No-
vato, CA, USA) and filled with aCSF. For all recording
experiments, after slices were transferred to a recording
chamber, a twisted bipolar stimulating electrode (FHC,
Bowdoinham, ME, USA) was placed in the Schaffer collat-
erals of area the CA3 region and fEPSPs were recorded
from the stratum radiatum of the CA1 region (Fig. 1). The
stimulation that elicited the highest response in peak ampli-
tude was determined and reduced to elicit approximately
30%–50% of the peak amplitude (pAmp) in order to control
for ceiling effects.
Fig. 1. Electrophysiological recordings on hippocampal slices. Anatomical
section of hippocampus depicting the major subregions of the hippocampus
and the positioning of electrodes for electrophysiological recordings. A
bipolar stimulating electrode was positioned in area CA3 for the stimula-
tion of the Schaffer collateral pathway and responses were recorded uti-Llizing a recording electrode positioned in the CA1 region.2.4.1. Basal synaptic transmission
Input/output (I/O) curves, curves depicting the response
to a stepwise increase in stimulation intensity in Y-S, O-S,
and O-GH, were used to examine the effect of chronic GH
treatment on age-related changes in basal glutamatergic
synaptic transmission. I/O curves were generated for com-
pound (CMPD), as well as AMPA-R and NMDA-R medi-
ated responses of neurons in the CA1 region following
electrical stimulation of the Schaffer collaterals. Compound
responses consisted of fEPSPs recorded under baseline con-
ditions. AMPA-R mediated fEPSPs were recorded in the
presence of APV and NMDA-R receptor fEPSPs were re-
corded in the presence of DNQX, bicuculline, and glycine.
The amplitude of 3 averaged fEPSPs, elicited at an inter-
pulse interval of 20 seconds utilizing the Axon Instru-
ments (Foster City, CA, USA) pCLAMP 9.0 software,
was plotted as a function of the logarithm exponent of
stimulus intensity (LogE(STIM)). Best-fit sigmoid curves were
reated to compare all 3 experimental groups under CMPD,
MPA-R, and NMDA-R recording conditions. The median
ffective stimulus intensity was determined from the best-fit
igmoid curve for each animal for CMPD, AMPA-R, and
MDA-R conditions. Because all curves reached a ceiling
ffect where the maximal response obtained was normalized
or all experimental groups, the median effective stimulus
ntensity was used to assess differences between animal
roups for all conditions. The median effective stimulus
ntensity was defined as the stimulus intensity that elicited
0% of the maximum obtainable pAmp.
.4.2. Paired-pulse ratios
A paired-pulse facilitation assay was used to assess
hanges in glutamate release probability (Xu-Friedman and
egehr, 2004; Zucker and Regehr, 2002). Pairs of fEPSPs
ere evoked at an interpulse interval of 50 ms and paired-
ulse ratios (PPRs) were calculated from the average of 5
airs of fEPSPs by dividing the peak of the second fEPSP
P2) by that of the first (P1) evoked pulse.
.4.3. LTP
Synaptic plasticity was assessed by examining changes
n LTP in slices from Y-S, O-S, and O-GH rats. LTP was
enerated by using a high frequency stimulus train pro-
rammed through the Axon Instruments pCLAMP LTP
ssistant by creating 2 subprotocols. The first subprotocol
licited pulses every 20 seconds at a stimulus intensity that
enerated approximately 30%–50% of the pAmp response
or 10–15 minutes. Field EPSPs recorded under the first
rotocol were used to establish a pre-LTP baseline. When a
table baseline was recorded, which was defined as a re-
ponse within 10% of the mean peak amplitude, the second
ubprotocol was utilized to generate a train of high-fre-
uency stimulation (HFS; 100 Hz) for 1 second in order to
nduce LTP. Recordings then were continued for 35 minutes
uring baseline stimulation with pulses every 20 seconds.
TP was defined as the sustained increase in potentiation
CC
(
1941D.P. Molina et al / Neurobiology of Aging 33 (2012) 1938–1949lasting for at least 35 minutes. Hippocampal slices were
discarded if the increase in potentiation was not sustained
for 35 minutes following HFS. Percent potentiation was
determined by comparing the last 5 minutes of potentiation
to the last 5 minutes of baseline recordings pre-LTP.
2.5. Western blotting
For Western blot analysis of glutamate receptor subunit
levels, Y-S, O-S, and O-GH rats (n  12 per group) were
anesthetized with sodium pentobarbital (150 mg/kg) and
decapitated, the brains were removed, and the hippocampus
dissected into subregions (Newton et al., 2005). Protein
levels of subunits in the hippocampal subregion CA1 were
determined in Western blot experiments as described pre-
viously (Shi et al., 2006, 2007). Briefly, tissue was homog-
enized using a Laemmli-based buffer supplemented with
protease inhibitors and protein concentrations were deter-
mined using the bicinchoninic acid (BCA) method (Pierce
Technology, Rockford, IL, USA). For analysis of NMDA-R
and AMPA-R subunits levels, samples were loaded onto
gels, separated using sodium dodecyl sulfate-polyacrylam-
ide gel electrophoresis (SDS-PAGE), transferred onto mem-
branes, and probed with the following primary antibodies:
rabbit monoclonal antibody to the NR1 (0.06 g/mL
Chemicon Billerica, MA, USA), NR2B (0.07 g/mL
hemicon), NR2A (0.07 g/mL, Chemicon), GluR1 (0.01
g/mL, Upstate, Placid, NY, USA), GluR2 (0.25 g/mL,
hemicon), and mouse monoclonal antibody to actin
0.002 g/mL, Chemicon). Peroxidase-conjugated don-
key anti-rabbit IgG (10 ng/mL, Jackson ImmunoResearch
Laboratories, West Grove, PA, USA) and peroxidase-
conjugated donkey anti-mouse IgG (10 ng/mL, Jackson
Laboratory) secondary antibodies were used with Super-
Signal West Pico chemiluminescent Substrate (Pierce
Technology) for detection. Blots were exposed on Kodak
Biomax film (Sigma-Aldrich, St. Louis, MO, USA) and
individual bands were quantified with Bio-Rad VersaDoc
and Quantity one analysis software (Bio-Rad Laborato-
ries, Hercules, CA, USA) in order to determine the rel-
ative amounts of each protein. The Gaussian trace optical
density of each band was normalized to the average
density of all of the matching bands within each cohort to
permit comparison among blots and experiments. Each
cohort represents 1 animal from each of the 3 different
treatment groups and the matching bands are bands that
represent 1 of the proteins, i.e., NR1. A repeated mea-
surement was excluded if it was greater than 2 standard
deviations away from the mean. Each blot was repeated
at least once, thus generating a minimum of 4 acceptable
measurements per antibody per sample. In each gel, actin
was measured as internal loading control. We did not
normalize our bands to these protein levels but looked for
group differences in the actin levels. This method of
quantifying protein levels in the subregions of the hip-
pocampus has been used previously by our laboratory in dmultiple studies (Adams et al., 2008; Newton et al., 2008;
Shi et al., 2006, 2007).
2.6. Enzyme-linked immunosorbent assay (ELISA)
IGF-I levels in plasma and hippocampus were deter-
mined as described previously (Adams et al., 2009). Briefly,
Y-S, O-S, and O-GH rats (n  12 per group) were anes-
thetized, cardiac blood was removed from the left ventricle
of the heart, centrifuged, and plasma IGF-I levels (reported
as mg IGF-I per mL plasma) were quantified using a mod-
ified ELISA (R & D Systems Quantikine mouse IGF-I
immunoassay; MG100; Minneapolis, MN, USA). After
blood samples were removed, rats were perfused transcar-
dially with phosphate-buffered saline containing 5 mM dex-
trose and decapitated. The hippocampus was removed and
homogenized in 1M acetate homogenization buffer for
IGF-I acid extraction. IGF-I levels in hippocampus (g
IGF-I per mg hippocampus) were determined using the
same ELISA modification as for plasma.
2.7. Statistics
The median effective stimulus intensity for CMPD,
AMPA-R, and NMDA-R dependent I/O curves were ana-
lyzed using a 1-way analysis of variance (ANOVA) fol-
lowed by the Newman-Keuls post hoc test for pairwise
comparisons when appropriate. Paired-pulse ratios of the
second to the first evoked response were analyzed by a
1-way ANOVA followed by the Newman-Keuls post hoc
test. For the analysis of LTP, the percentage potentiation
above baseline in Y-S, O-S, and O-GH was analyzed by a
1-way ANOVA followed by the Newman-Keuls post hoc
test. The effect of GH on glutamatergic subunit proteins,
was examined by comparing the normalized Gaussian trace
optical densities for NR1, NR2A, NR2B, GluR1, GluR2,
and actin using a 1-way ANOVA followed by the Newman-
Keuls post hoc test. Finally, IGF-I levels in plasma and
hippocampus for each experimental group were analyzed by
a 1-way ANOVA followed by the Newman-Keuls post hoc
test. Statistical significance was defined as p  0.05. All
statistical analyses were done using SigmaStat 3.5 (Aspire
Software International, Ashburne, VA, USA) software;
GraphPad Prism 5 (GraphPad Software, Inc., San Diego,
CA, USA) was used for curve fitting.
3. Results
3.1. GH treatment alters AMPA- and NMDA-dependent
basal synaptic transmission
To determine the effect of 6–8 months of GH treatment
on basal synaptic transmission in the CA1 region of old rats,
the I/O relationship of fEPSPs recorded in slices prepared
from Y-S, O-S, and O-GH rats was examined. Best-fit
sigmoid curves were generated and the half maximal
LogE(STIM) (LogE(STIM1/2MAX)) was compared for all con-
itions. The results of the curve fitting analysis were similar
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LogE(STIM) determined for the CMPD responses showed no
group differences (p  0.997, Fig. 2A). The results of the
curve-fitting analysis for AMPA-R-dependent fEPSPs re-
vealed that although there were no age-related changes in
baseline responses, GH treatment enhanced AMPA-R syn-
aptic transmission as evidenced by the significant decrease
in the stimulation intensity required to evoke a half-maxi-
mal AMPA-R fEPSP response (Fig. 2B). The results of the
curve-fitting analysis for NMDA-R-dependent fEPSPs dem-
onstrated that a stronger stimulation intensity was required
to elicit half-maximal responses in O-S rats compared with
Y-S rats, and this effect is reversed by GH treatment
(Fig. 2C).
To determine whether chronic GH treatment altered glu-
tamate release at excitatory synapses in the CA1 region, we
measured PPRs in Y-S, O-S, and O-GH rats. PPR is the
ratio between the second stimulus pulse (P2) and the first
stimulus pulse (P1) with an interpulse interval of 50 ms.
Changes in the PPR are often used as an indicator of
alterations in neurotransmitter release probability, consis-
tent with changes of presynaptic origin (Xu-Friedman and
Regehr, 2004; Zucker and Regehr, 2002). The results indi-
cate no difference among Y-S, O-S, and O-GH rats in PPRs
recorded in hippocampal slices (p  0.662; Fig. 3).
3.2. GH treatment enhances long-term potentiation
To assess the effect of GH treatment on synaptic plas-
ticity we utilized an HFS protocol (100 Hz per 1 second
duration) to elicit LTP of CMPD CA1 region fEPSPs in
hippocampal slices from Y-S, O-S, and O-GH rats. In slices
from all 3 groups, HFS elicited a rapid increase in the
amplitude of fEPSPs followed by a sustained potentiation,
or LTP, that lasted for at least 30–35 minutes after induc-
tion (Fig. 4A). The average pAmp response of the last 5
minutes of sustained LTP was compared with the last 5
minutes of baseline recordings, and the percentage potenti-
ation above baseline was derived. Hippocampal slices from
O-GH rats exhibited an enhanced potentiation compared
with both Y-S and O-S rats (Fig. 4A). Importantly, analysis
of the percentage potentiation indicated that LTP in O-GH
rats was significantly enhanced compared with O-S rats
(p  0.016; Fig. 4B).
3.3. Glutamate receptor subunit levels are unaltered by
GH treatment
In order to determine whether chronic GH treatment
altered total protein levels of NMDA-R and AMPA-R sub-
units in the CA1 region, Western blot analysis was used to
compare relative protein levels of those subunits in Y-S,
O-S, and O-GH rats (Fig. 5). Our results demonstrated that
there were no age-related differences in protein levels for
NMDA-R subunits NR1 or NR2A (all p-values 0.05; Fig.
6). However, an age-related difference was detected for
subunit NR2B (p 0.001; Fig. 6). As with NMDA subunits BR1 and NR2A, AMPA-R subunits and actin did not ex-
ibit a difference in levels with age (all p-values  0.05;
ig. 6). In addition, all subunit and actin levels did not differ
ignificantly between O-S and O-GH (all p-values  0.05;
ig. 6).
.4. IGF-I plasma and hippocampal levels are unaltered
y GH treatment
IGF-I levels in plasma and hippocampus were assessed
o determine if those levels were altered by the chronic GH
reatment in old rats (Fig. 7A and B). This is the same GH
reatment that enhanced AMPA-R and NMDA-R dependent
asal synaptic transmission and synaptic plasticity in CA1
egion of old animals. Neither plasma nor hippocampal
evels of IGF-I differed significantly between O-S and
-GH rats (both p-values  0.05) or between Y-S and O-S
both p-values  0.05) rats; however, plasma IGF-I was
ignificantly less in O-GH compared with Y-S rats (p 
.001; Fig. 7A). Furthermore, we observed a significant
ncrease in body weight with age but not with treatment
data not shown; mean  standard error: Y-S 473  17.4 g;
-S 585  18.5 g; O-GH 623  16.4 g; for Y-S both
-values  0.005 and for O-S and O-GH p  0.564).
. Discussion
The results of this study provide the first evidence of an
ffect of chronic GH treatment on basal excitatory synaptic
ransmission and synaptic plasticity in the hippocampus. Six
o 8 months of twice daily GH treatment enhanced AMPA-
-dependent synaptic transmission and ameliorated the age-
elated deficit in NMDA-R-dependent synaptic transmission
n old Fisher 344  Brown Norway rats. In addition, GH
reatment increased the magnitude of LTP, indicating en-
anced synaptic plasticity. The absence of GH-induced
hanges in paired-pulse facilitation further suggests that the
bserved enhancement in synaptic transmission may not be
ediated by presynaptic facilitation of glutamate release. In
ddition, the observed changes in synaptic transmission and
lasticity following chronic GH treatment occurred in the
bsence of either alterations in levels of glutamate receptor
ubunits or elevations in plasma or hippocampal IGF-I lev-
ls in the CA1 region.
.1. Basal synaptic transmission
Aging alters basal excitatory transmission in old rats. We
bserved a significant decrease in NMDA receptor function
n old rats. These data are consistent with that from Eckles-
mith et al. (2000) and Barnes et al. (1997). While we did
bserve an age-related decline in the NMDA receptor-me-
iated fEPSP in old rats, we saw no age-related change in
he AMPA-R mediated fEPSP like that described by Barnes
t al. (1997). The dissimilarity in the 2 results may result
rom the use of 2 different strains of rats. In the study by
arnes et al. (1997) F344 rats were used and in the present
rg
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1943D.P. Molina et al / Neurobiology of Aging 33 (2012) 1938–1949Fig. 2. Curve fitting analysis of compound (CMPD), -amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), and N-methyl-D-aspartate (NMDA)
esponses. Compound input/output (I/O) curves (A), AMPA receptor (R)-mediated I/O curves (B), and NMDA receptor (R)-mediated I/O curves (C) were
enerated from hippocampal CA1 field recordings. The stimulus intensity required to elicit the half-maximal response in each experimental group was
ompared as demonstrated by the bar graph. (A) Compound I/O curves were unaffected by age or growth hormone (GH) treatment, p  0.997.
1944 D.P. Molina et al / Neurobiology of Aging 33 (2012) 1938–1949experiments the hybrid strain of the F344 X Brown Norway
animals was used. In addition, we observed no difference in
the CMPD responses between young and old rats consistent
with the idea that age-related changes in the hippocampus
are very subtle. Interestingly, GH treatment significantly
reversed the age-related decline in the NMDA receptor-
mediated fEPSPs and enhanced the AMPA-R-mediated
fEPSPs in old rats. Thus, GH alters the age-related course of
excitatory transmission.
The data demonstrated subtle age-related changes in basal
excitatory transmission. Compared with the young saline-
treated rats, old saline-treated rats demonstrated a decline in
NMDA-R-dependent, but not in AMPA-R-dependent fEPSPs.
Our data revealed that this decline in synaptic transmission
occurs in the absence of any alterations in the NMDA-R
subunits NR1 and NR2A and AMPA-R subunits GluR1 and
GluR2 tissue protein levels. However, consistent with a reduc-
tion in NMDA-R-dependent synaptic function the NMDA-R
subunit NR2B is observed to decrease with age, and thus could
contribute to the observed deficit in NMDA-R-dependent syn-
aptic transmission. Although both AMPA-R and NMDA-R-
dependent synaptic transmission were enhanced by chronic
GH treatment, GH treatment did not lead to the alteration of
protein levels of any of the subunits in the CA1 region. Nev-
ertheless, an absence of a difference in subunit levels between
old saline-treated and old GH-treated groups does not rule out
an effect of GH on NMDA-R or AMPA-R subunits in the CA1
region. For example, subunit changes could occur within an
individual layer in the CA1 region, but be masked by the
stability of subunit protein levels in the other layers. Such a
layer-specific change is seen in the age-related decline in syn-
aptophysin levels that are limited to the stratum laconosum
(B) AMPA-R-mediated field excitatory postsynaptic potentials (fEPSPs)
GH-treated rats showed significant enhancement (p  0.01; * Old GH si
fEPSPs declined with age p  0.001, and these responses were enhanced b
Fig. 3. Presynaptic facilitation. Bar graph illustrating the paired-pulse ratio
(amplitude pulse 2/amplitude pulse 1, interpulse interval: 50 ms) of field
excitatory postsynaptic potentials (fEPSPs) recorded from young saline
rats and in old rats treated with either saline or growth hormone (GH). No
group differences in this measure were observed, p  0.05.0.011 and young saline rat groups, p  0.008 (* Old Saline significantly differenmoleculare in the CA3 region (Smith et al., 2000). In addition,
subunit changes limited to the postsynaptic density could be
obscured by a stability of subunits in the cytosol as suggested
by reports indicating that synaptic fractions reveal subtle
changes in subunit expression levels that are not evident in the
whole homogenate (Zhao et al., 2009).
4.2. Long-term potentiation
Our findings indicate that there was not a significant
decline in LTP with age nevertheless a trend toward a
decline was observed, and LTP was enhanced in GH-treated
old rats compared with old saline-treated rats. Previous
studies have demonstrated that there is a decline in LTP
with age (Barnes et al., 1997; Eckles-Smith et al., 2000).
The discrepancy between previous findings and our findings
may be attributed to subtle differences in response to LTP
protocols. A previous study demonstrated that, while LTP
was generated robustly in young and old rats by multiple
episodes of theta-burst stimulation and paired low fre-
quency stimulation, no difference in the magnitude of LTP
was observed (Kumar et al., 2007). Thus, while aging may
impair LTP, this alteration may be masked by differences in
protocols used to elicit LTP.
The HFS protocol used here to induce LTP is well-recog-
nized to be dependent on NMDA-R function (Collingridge et
al., 1983; Kimura et al., 1989; Morris et al., 1986). Interest-
ingly, not only do our findings indicate that basal NMDA-R
function was significantly increased by chronic GH treatment
we also observed a significant enhancement in LTP following
GH treatment in old rats. Acute GH treatment has also been
observed to play a direct role in the enhancement of NMDA-
R-dependent basal synaptic transmission in juvenile (1.5–3-
month-old; Mahmoud and Grover, 2006), as well as young
adult (10-month-old) and old (28-month-old) rats (Molina et
al., unpublished observations). Furthermore, Mahmoud and
Grover (2006) demonstrated that although GH induced a ro-
bust enhancement of synaptic transmission in hippocampal
slices, this GH-induced enhancement could be prevented by
eliciting LTP induced by HFS prior to GH application. Simi-
larly a pretreatment of slices with GH prevented LTP induced
by HFS. This finding suggests that GH shares at least some of
the signaling mechanisms involved in tetanus-induced LTP,
and thus, acute GH application can induce LTP and lead to
LTP saturation preventing further potentiation (Castro et al.,
1989; Mahmoud and Grover, 2006; McNaughton et al., 1986;
Moser et al., 1998). One possible mechanism whereby GH
could be influencing NMDA-R-dependent transmission is
through the regulation of NMDA-R composition at the syn-
apse. Specifically, changes in the ratio of NR1/NR2A and
t differ between young and old saline-treated rats, but slices from old
tly different from young and old saline groups). (C) NMDA-R-mediated
ic GH treatment to a greater responsiveness than that observed in old p did no
gnifican
y chront from young saline and old GH groups).
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1945D.P. Molina et al / Neurobiology of Aging 33 (2012) 1938–1949NR1/N2RB receptor subunits which are reported to be asso-
ciated with changes in LTP (Liu et al., 2004) could be occur-
ring in GH-treated rats that have stable cellular levels of indi-
vidual subunits. For instance, long-term depression (LTD) but
not LTP was abolished in hippocampal slices in which the
proportion of the NR2B subunit was reduced by the selective
NR2B blocker ifenprodil and the specific antagonist Ro25-
6981. Furthermore, preferential inhibition of the NR2A subunit
by the NR2A specific antagonist NVP-AAM077 prevented
LTP (Liu et al., 2004).
Alterations in the proportions of NR2A and NR2B sub-
units in NMDA-R complexes also could alter membrane
properties, particularly Ca2 regulation which in turn could
impact LTP. In addition the source of Ca2, whether intra-
cellular or extracellular, also plays a role in the direction of
Fig. 4. Long-term potentiation (LTP). The time course of LTP induction in
represented as percent amplitude of enhancement compared with baseline
minutes) compared with the baseline (1–5 minutes) (B) for each treatment
old saline rats p  0.016 (*); young saline rats did not differ significantly
Fig. 5. Representative Western blots for synaptic proteins in the CA1
region of hippocampus. Western blot analysis was performed to assess
CA1 protein levels of the N-methyl-D-aspartate (NMDA) subunits NR2A,
NR1, and NR2B, and the alpha-amino-3-hydroxy-5-methyl-4-isoxazole-
propionate (AMPA) subunits GluR1 and GluR2. Actin was assessed on
each blot to insure equal protein loading. Experimental groups were: lane
1, young saline-treated; lane2, old saline-treated; and lane 3, old growthrhormone (GH)-treated Fischer 344  Brown Norway rats.synaptic plasticity. For example, lowering the extracellular
Ca2 concentration in a slice medium during electrophysi-
logical recordings can change a protocol that normally
nduces LTD to 1 that produces LTP in the hippocampal
A1 region (Mulkey and Malenka, 1992). In addition
R2B containing receptors are reduced in aged animals;
his reduction has been demonstrated to reduce LTP and
ompromise learning and memory (Clayton et al., 2002).
hus, impairment in NMDA-R-dependent Ca2 regulation
ith age could contribute to a reduction in LTP. For in-
tance, a decrease in NR2B levels with age could be asso-
iated with a decrement in extracellular Ca2 levels, which
as been observed in aged rats (Audinat et al., 1994; Camp-
ell et al., 1996; Clayton et al., 2002; Thibault et al., 1998;
allano et al., 1996). Importantly, GH has been shown to
ncrease cytoplasmic Ca2 levels in BRIN-B11 cells, and
this augmentation can be ablated by blocking elements of
the GH signaling cascade (Zhang et al., 2006). Thus, the
GH-induced enhancement of LTP reported here could in-
volve alterations to the subunit composition of NMDA-R at
the postsynaptic membrane as well as GH-mediated changes to
intracellular Ca2 levels.
In addition to changes in the ratio of subunits comprising
the NMDA-R, the properties of individual AMPA-R and
NMDA-R subunits can be altered by posttranslational mod-
ifications such as phosphorylation. Phosphorylation can
change the properties of receptor subunits and these changes
can contribute to LTP enhancement. For instance, protein
kinase C (PKC) and Ca2 calmodulin kinase II (CaMKII)
re known to phosphorylate glutamate receptor subunits
R1 and GluR1, respectively (Cammarota et al., 1998; Kim
t al., 2008). Phosphorylation of these 2 subunits has been
saline rats and in old rats treated with saline or growth hormone (GH) is
alysis of the percentage potentiation in the last 5 minutes of LTP (30–35
revealed that LTP in old GH-treated rats was significantly greater than in
either old group.young
(A). An
groupeported to underlie the enhancement in LTP that occurs
1946 D.P. Molina et al / Neurobiology of Aging 33 (2012) 1938–1949after treatment with nefiracetam, a nootropic drug reported
to improve cognitive function and memory (Moriguchi et
al., 2008). Thus, the GH-induced enhancement in LTP
could be mediated by increasing the activation of kinases
involved in the phosphorylation of NMDA and AMPA-R
Fig. 6. Assessment of glutamate receptor subunit protein level changes. De
relative levels of the NR1, NR2A, and NR2B subunits of the N-meth
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) recepto
0.001), an effect that was not mitigated by growth hormone (GH) treatm
Chronic GH treatment twice daily for 6–8 months did not produce a signific
with that present in old saline-treated animals.subunits.4.3. Insulin-like growth factor-I
Considerable evidence in the literature suggests that
IGF-I can serve as a mediator of the actions of GH, and the
neurobiological effects of GH treatment are often attributed
tric Western blot analysis of subunit proteins in the CA1 region evaluated
partate (NMDA) receptor, and the GluR1 and GluR2 subunits of the
analysis revealed that only NR2B declined significantly with age (p 
oung saline significantly different from old saline and old GH groups).
nge in the protein levels of any of the NMDA or AMPA subunits comparednsitome
yl-D-as
r. The
ent (* Y
ant chato a secondary increase in plasma levels of IGF-I (Florini
h1947D.P. Molina et al / Neurobiology of Aging 33 (2012) 1938–1949and Ewton, 1981; Sonntag et al., 1980). Consistent with this
notion, treatment with GH and IGF-I have similar benefits
for cognitive function in old animals (Markowska et al.,
1998; Ramsey et al., 2004; Sonntag et al., 2000). In the
present study, the data indicate that GH treatment resulted in
enhanced synaptic transmission and plasticity in the absence
of elevated IGF-I levels in either plasma or hippocampal
tissue, suggesting a direct role for GH in the amelioration of
age-related changes in synaptic function. Consistent with
this possibility, recent studies have demonstrated that acute
application of GH enhanced glutamatergic transmission in
hippocampal slices from 1.5- to 3-month-old (Mahmoud
and Grover, 2006) as well as from 10- and 28-month-old
rats (Molina et al., unpublished observations). Importantly,
GH receptors are expressed in the hippocampus as well as
elsewhere in the brain (Burton et al., 1992; Fraser et al.,
1990; Hull and Harvey, 1998; Lobie et al., 1993; Walsh et
al., 1990; Zhai et al., 1994) and GH has been shown to cross
the blood-brain barrier (Pan et al., 2005). Taken together,
these studies and the present findings demonstrate that GH
can act directly on the nervous system.
4.4. Summary
In summary, the present study demonstrates a direct role
for GH in the mitigation of age-related changes in basal
synaptic transmission and synaptic plasticity in the CA1
region of the hippocampus. This GH-mediated mitigation
may contribute to the reported benefits of chronic GH treat-
Fig. 7. Examination of insulin-like growth factor-I (IGF-I) plasma and tiss
of young saline rats and old rats treated with either saline or growth hormo
rats fell short of significance (p  0.098). Plasma IGF-I levels in old rats
significantly lower than in young saline-treated rats p  0.02 (* Youn
ippocampus did not differ with age or GH injection.ment on cognitive impairment in old animals. Although theexact postsynaptic mechanism(s) through which GH en-
hances the activity of AMPA-R and NMDA-R will require
additional study, they likely involve the regulation of recep-
tor subunits at the postsynaptic membrane, either by in-
creasing synaptic levels of the receptors or potentially al-
tering their phosphorylation state. The changes in synaptic
transmission and plasticity following chronic GH treatment
reported here provide compelling evidence for a direct role
for GH in the mediation of cellular events that are critical
for the maintenance of optimal synaptic function. These
data are consistent with the possibility that AMPA-R and
NMDA-R provide potential targets for therapeutic interven-
tions that could ultimately contribute to the enhancement of
cognitive function in the elderly.
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